Bioactive Wound Care Market Analysis by Product (Moist Wound Care, Antimicrobial Wound Care, Active Wound Care) And Segment Forecasts To 2024

Published: Sep, 2016 | Pages: 80 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global bioactive wound care market is expected to reach USD 11.9 billion by 2024, according to a new report by Grand View Research, Inc. The prevalence of chronic skin conditions, such as pressure ulcers, diabetic foot, and other skin-related infections is on the rise. Bioactive wound care products offer available line of treatment, which act efficiently in curing the aforementioned conditions.

Hence, with the increasing target population, the bioactive wound care market is estimated to witness lucrative growth. Rise in awareness among the patients regarding personal hygiene is augmenting the demand for these products. The raised awareness levels cause patients to seek physicians' advice at an early stage thus enabling timely interventions.

Rising per capita healthcare expenditure in the recent years and the increasing disposable income is enabling the population to spend a substantial amount on healthcare facilities, thereby contributing towards the growth of the market. The development of advanced products, such as combination wound dressings containing multiple ingredients that offer several benefits to patients, is anticipated to boost the demand for these products.

Further key findings from the study suggest:

The moist wound care products segment held a lucrative share of more than 50.0% in 2015. The ability of these products to create a supportive moist environment, which expedites the healing process, is a notable feature of these products. Moist wound care products include foams, films, alginates, hydrocolloids, and hydrogels.

The antimicrobials segment, comprising products impregnated with silver and non-silver ingredients, is anticipated to witness profitable growth over the forecast period. These products are cost efficient with lower chances of developing resistance to antimicrobial products.

The segment of active wound care products, likewise, is anticipated to exhibit a significant growth rate in the coming 8 years. Recently, the U.S. Food and Drug Administration approved a couple of biomaterials, Dermagraft, and Alpigraph, for management of skin-related injuries. The ability of these products to mimic biological properties is a key advantage that enables a faster healing process.

North America contributed with a share of more than 30.0% of the global bioactive wound care market. Presence of major players, streamlined regulations, and favorable reimbursement policies are some of the key contributing factors responsible for the growth of this region.

Asia Pacific with its huge potential is anticipated to witness considerable growth over the forecast period. The presence of a huge untapped population, stirring economic developments in this region, and consistent efforts undertaken to improve the healthcare infrastructure are the key growth drivers.

The key players in this industry include Smiths & Nephew, Molnlycke Health Care, ConvaTec, Inc., Paul Hartmann AG, Organogenesis, Inc., Systagenix Wound Management Ltd., 3M Healthcare Ltd., Medtronic, Covalon Technologies Ltd., BSN Medical, and Medline Industries, Inc.

The strategic endeavors undertaken by the leading players in the industry include new product launches, collaborations with government bodies, and R&D investments.

In July 2015, Smith & Nephew acquired DeOst LLC and DeLLC, part of the DeOST group, which is a manufacturer of medical devices in Russia. This acquisition is expected to help companies expand their global footprints.

 Table of Contents


Chapter 1. Methodology and Scope
                     1.1. Research Methodology
                     1.2. Research Scope & Assumptions
                     1.3. List of Data Sources
Chapter 2. Executive Summary
                     2.1. Bioactive Wound Care Market- Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Bioactive Wound Care Industry Outlook
                     3.1. Bioactive Wound Care Market Segmentation
                     3.2. Bioactive Wound Care Market Size and Growth Prospects
                     3.3. Bioactive Wound Care Market Dynamics
                          3.3.1. Market driver analysis
                          3.3.2. Market restraint analysis
                     3.4. Key Opportunities Prioritized
                     3.5. Industry Analysis: Porter's
                     3.6. Bioactive Wound Care Market PESTEL Analysis, 2015
Chapter 4. Bioactive Wound Care Market, by Product
                     4.1. Bioactive Wound Care Market Share, By Product, 2015 & 2024 (USD Million)
                     4.2. Moist Wound Care
                          4.2.1. Moist wound Care Market estimates and forecasts, 2013 - 2024 (USD Million)
                          4.2.2. Foam-based wound dressings
                               4.2.2.1. Foam-based wound dressings market estimates and forecasts, 2013 - 2024 (USD Million)
                          4.2.3. Alginate wound dressings
                               4.2.3.1. Alginate wound dressings market estimates and forecasts, 2013 - 2024 (USD Million)
                          4.2.4. Film
                               4.2.4.1. Film dressings market estimates and forecasts, 2013 - 2024 (USD Million)
                          4.2.5. Hydrocolloid
                               4.2.5.1. Hydrocolloid-based wound dressings market estimates and forecasts, 2013 - 2024 (USD Million)
                          4.2.6. Hydrogel
                               4.2.6.1. Hydrogel wound dressings market estimates and forecasts, 2013 - 2024 (USD Million)
                     4.3. Antimicrobial Wound Care
                          4.3.1. Silver-based wound dressings market estimates and forecasts, 2013 - 2024 (USD Million)
                          4.3.2. Non-silver Wound Dressings
                               4.3.2.1. Non-silver wound dressings market estimates and forecasts, 2013 - 2024 (USD Million)
                     4.4. Active Wound Care
                          4.4.1. Active wound Care Market estimates and forecasts, 2013 - 2024 (USD Million)
                          4.4.2. Biomaterial
                               4.4.2.1. Biomaterial dressings market estimates and forecasts, 2013 - 2024 (USD Million)
                               4.4.2.2. Skin substituents
                               4.4.2.3. Skin substituents market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 5. Bioactive Wound Care Market, By Region
                     5.1. Bioactive Wound Care Market Share, by Region,2015 & 2024 (USD Million)
                     5.2. North America 
                          5.2.1. North America market estimates and forecasts, 2013 - 2024 (USD Million)
                          5.2.2. U.S.
                               5.2.2.1. U.S. market estimates and forecasts, 2013 - 2024 (USD Million) 
                               5.2.2.2. U.S. market estimates and forecastsby product 2013 - 2024 (USD Million)
                          5.2.3. Canada
                               5.2.3.1. Canada market estimates and forecasts, 2013 - 2024 (USD Million) 
                               5.2.3.2. Canada market estimates and forecasts,by product, 2013 - 2024 (USD Million)
                     5.3. Europe 
                          5.3.1. Europe market estimates and forecasts, 2013 - 2024 (USD Million)
                          5.3.2. UK
                               5.3.2.1. UK market estimates and forecasts, 2013 - 2024 (USD Million) 
                               5.3.2.2. UK market estimates and forecasts,by product, 2013 - 2024 (USD Million)
                          5.3.3. Germany
                               5.3.3.1. Germany market estimates and forecasts, 2013 - 2024 (USD Million) 
                               5.3.3.2. Germany market estimates and forecasts,by product 2013 - 2024 (USD Million)
                          5.3.4. Asia Pacific Market Estimates and Forecasts , 2013 - 2024 (USD Million)
                          5.3.5. Japan
                               5.3.5.1. Japan market estimates and forecasts, 2013 - 2024 (USD Million) 
                               5.3.5.2. Japan market estimates and forecasts,by product 2013 - 2024 (USD Million)
                          5.3.6. China
                               5.3.6.1. China market estimates and forecasts, 2013 - 2024 (USD Million) 
                               5.3.6.2. China market estimates and forecasts,by product 2013 - 2024 (USD Million)
                     5.4. Latin America 
                          5.4.1. Latin America market estimates and forecasts, 2013 - 2024 (USD Million)
                          5.4.2. Brazil
                               5.4.2.1. Brazil market estimates and forecasts, 2013 - 2024 (USD Million) 
                               5.4.2.2. Brazil market estimates and forecasts,by product 2013 - 2024 (USD Million)
                          5.4.3. Mexico
                               5.4.3.1. Mexico market estimates and forecasts, 2013 - 2024 (USD Million) 
                               5.4.3.2. Mexico market estimates and forecasts,by product 2013 - 2024 (USD Million)
                     5.5. MEA 
                          5.5.1. MEA market estimates and forecasts, 2013 - 2024 (USD Million)
                          5.5.2. South Africa
                               5.5.2.1. South Africa market estimates and forecasts, 2013 - 2024 (USD Million) 
                               5.5.2.2. South Africa market estimates and forecasts,by product 2013 - 2024 (USD Million)
                          5.5.3. Saudi Arabia
                               5.5.3.1. Saudi Arabia market estimates and forecasts, 2013 - 2024 (USD Million) 
                               5.5.3.2. Saudi Arabia market estimates and forecasts, by product 2013 - 2024 (USD Million)
Chapter 6. Competitive Landscape
                     6.1. Smiths & Nephew
                          6.1.1. Company Overview
                          6.1.2. Financial Performance
                          6.1.3. Product Benchmarking
                          6.1.4. Strategic Initiatives
                     6.2. ConvaTec, Inc.
                          6.2.1. Company Overview
                          6.2.2. Financial Performance
                          6.2.3. Product Benchmarking
                          6.2.4. Strategic Initiatives
                     6.3. Molnlycke Health Care
                          6.3.1. Company Overview
                          6.3.2. Financial Performance
                          6.3.3. Product Benchmarking
                          6.3.4. Strategic Initiatives
                     6.4. Paul Hartmann AG
                          6.4.1. Company Overview
                          6.4.2. Financial Performance
                          6.4.3. Product Benchmarking
                          6.4.4. Strategic Initiatives
                     6.5. Systagenix Wound Management Ltd.
                          6.5.1. Company Overview
                          6.5.2. Financial Performance
                          6.5.3. Product Benchmarking
                          6.5.4. Strategic Initiatives
                     6.6. Organogenesis Inc.
                          6.6.1. Company Overview
                          6.6.2. Financial Performance
                          6.6.3. Product Benchmarking
                          6.6.4. Strategic Initiatives
                     6.7. Medtronic
                          6.7.1. Company Overview
                          6.7.2. Financial Performance
                          6.7.3. Product Benchmarking
                          6.7.4. Strategic Initiatives
                     6.8. 3M Health Care
                          6.8.1. Company Overview
                          6.8.2. Financial Performance
                          6.8.3. Product Benchmarking
                          6.8.4. Strategic Initiatives
                     6.9. Covalon Technologies Ltd.
                          6.9.1. Company Overview
                          6.9.2. Financial Performance
                          6.9.3. Product Benchmarking
                          6.9.4. Strategic Initiatives
                     6.10. BSN Medical
                          6.10.1. Company Overview
                          6.10.2. Financial Performance
                          6.10.3. Product Benchmarking
                          6.10.4. Strategic Initiatives
                     6.11. Medline Industries
                          6.11.1. Company Overview
                          6.11.2. Financial Performance
                          6.11.3. Product Benchmarking
                          6.11.4. Strategic Initiatives

List of Tables


TABLE 1 Bioactive wound care market - Industry Summary & Key Buying Criteria 
TABLE 2 Bioactive wound care market, by product, 2013 - 2024 (USD Million)
TABLE 3 Bioactive wound care market, by region, 2013 - 2024 (USD Million)
TABLE 4 Bioactive wound care - Key market driver analysis
TABLE 5 Bioactive wound care - Key market restraint analysis
TABLE 6 North America bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 7 North America moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 8 North America antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 9 U.S. bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 10 U.S. moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 11 U.S. antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 12 U.S. active wound care market, by type 2013 - 2024 (USD Million)
TABLE 13 Canada bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 14 Canada moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 15 Canada antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 16 Canada active wound care market, by type 2013 - 2024 (USD Million)
TABLE 17 Europe bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 18 Europe moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 19 Europe antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 20 Europe active wound care market, by type 2013 - 2024 (USD Million)
TABLE 21 UK bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 22 UK moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 23 UK antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 24 UK active wound care market, by type 2013 - 2024 (USD Million)
TABLE 25 Germany bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 26 Germany moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 27 Germany antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 28 Germany active wound care market, by type 2013 - 2024 (USD Million)
TABLE 29 Asia Pacific bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 30 Asia Pacific moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 31 Asia Pacific antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 32 Asia Pacific active wound care market, by type 2013 - 2024 (USD Million)
TABLE 33 Japan bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 34 Japan moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 35 Japan antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 36 Japan active wound care market, by type 2013 - 2024 (USD Million)
TABLE 37 China bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 38 China moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 39 China antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 40 China active wound care market, by type 2013 - 2024 (USD Million)
TABLE 41 Latin America bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 42 Latin America moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 43 Latin America antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 44 Latin America active wound care market, by type 2013 - 2024 (USD Million)
TABLE 45 Brazil bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 46 Brazil moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 47 Brazil antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 48 Brazil active wound care market, by type 2013 - 2024 (USD Million)
TABLE 49 Mexico bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 50 Mexico moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 51 Mexico antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 52 Mexico active wound care market, by type 2013 - 2024 (USD Million)
TABLE 53 MEA bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 54 MEA moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 55 MEA antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 58 MEA active wound care market, by type 2013 - 2024 (USD Million)
TABLE 59 South Africa bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 60 South Africa moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 61 South Africa antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 62 South Africa active wound care market, by type 2013 - 2024 (USD Million)
TABLE 63 Saudi Arabia bioactive wound care market, by product 2013 - 2024 (USD Million)
TABLE 64 Saudi Arabia moist wound care market, by product 2013 - 2024 (USD Million)
TABLE 65 Saudi Arabia antimicrobial wound care market, by product 2013 - 2024 (USD Million)
TABLE 66 Saudi Arabia active wound care market, by type 2013 - 2024 (USD Million)